Which returned more over the last year, VCSH or XBI?

In the year to Sep 12, 2026, with distributions reinvested, VCSH returned +1.6% and XBI returned +64.0%, so XBI returned more. One year is one year; the longer windows are in the table.

Which is cheaper, VCSH or XBI?

VCSH charges 0.03% a year and XBI charges 0.35%, so VCSH is cheaper. Fees come from each fund's prospectus.

Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.

ETFIQetfiq.com · independent ETF data

VCSH vs XBI: how they differ

VCSH and XBI hold 0% of their weight in the same names, and XBI returned more over the year.

Vanguard Short-Term Corporate Bond Index Fund and State Street(R) SPDR(R) S&P(R) Biotech ETF.

What they hold in common

By the books each fund has filed, VCSH and XBI hold 0% of their money in the same securities at the same weight.

Largest positions each one holds and the other does not
Only in VCSH	Only in XBI
United States Treasury Note/Bond 0.85%	Apogee Therapeutics Inc 1.49%
Bank of America Corp 0.24%	Moderna Inc 1.41%
AbbVie Inc 0.21%	Twist Bioscience Corp 1.41%
CVS Health Corp 0.21%	Oruka Therapeutics Inc 1.38%
T-Mobile USA Inc 0.20%	Kymera Therapeutics Inc 1.36%
Boeing Co/The 0.20%	Viking Therapeutics Inc 1.31%
Wells Fargo & Co 0.18%	Praxis Precision Medicines Inc 1.29%
JPMorgan Chase & Co 0.18%	Erasca Inc 1.27%

Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026 and May 31, 2026.

VCSH and XBI on the fields both publish, as of Sep 12, 2026. Source: ETFIQ.
	VCSH Vanguard Short-Term Corporate Bond Index Fund	XBI State Street(R) SPDR(R) S&P(R) Biotech ETF
Where it sits	Core index fund	Core index fund
Issuer	Vanguard	State Street
What it is	Short-Term Corporate Bond	SPDR S&P Biotech
Total return, 1 year	+1.6%	+64.0%
S&P 500 over the same days	+17.5%	+17.5%
Gap to the S&P 500	−15.9 pts	+46.5 pts
Expense ratio	0.03%	0.35%
Holdings	2999	150

VCSH in plain words

VCSH is a bond fund tracking the Short-Term Corporate Bond. Over the year to Sep 11, 2026 it returned +1.6% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.03% a year.

XBI in plain words

XBI is an index equity fund tracking the SPDR S&P Biotech. Over the year to Sep 11, 2026 it returned +64.0% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.35% a year. By its holdings filed for Jun 30, 2026, 8% of the fund by weight is stocks the S&P 500 also holds, across 150 positions, with the top ten at 13.3%. It sat 9.6% below its high of Feb 8, 2021 on Sep 11, 2026.

Questions people ask

Which returned more over the last year, VCSH or XBI?: In the year to Sep 12, 2026, with distributions reinvested, VCSH returned +1.6% and XBI returned +64.0%, so XBI returned more. One year is one year; the longer windows are in the table.
Which is cheaper, VCSH or XBI?: VCSH charges 0.03% a year and XBI charges 0.35%, so VCSH is cheaper. Fees come from each fund's prospectus.

Other comparisons

Where to next

Where these figures came from

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

VCSH against XBI, ETFIQ, data as of Sep 12, 2026. Every figure is arithmetic on a named public source; the method is at etfiq.com/methodology. A comparison is not a recommendation.

Cite this page. ETFIQ, VCSH against XBI, data as of Sep 12, 2026. https://etfiq.com/compare/any/VCSH-XBI Free to use with attribution; the underlying files are at Open data.

A comparison is not a recommendation. Standards and sources